Digestive Diseases and Sciences

, Volume 52, Issue 12, pp 3488–3492 | Cite as

The Effect of Acetaldehyde on Human Plasma Factor XIII Function

  • Elizabeth A. Suchocki
  • Arthur S. Brecher
Original Paper


The effect of acetaldehyde on the transglutaminase activity in pooled normal human plasma has been investigated. In this study, 0.05, 0.2, and 0.7 ml of pooled human plasma were preincubated for 30 min. at room temperature with buffer or acetaldehyde at final concentrations of 40.6, 22.4, and 11.2 mM before being utilized for Factor XIIIa assay with fibrinogen and thrombin which had been preheated at 40°C to destroy endogenous Factor XIII/XIIIa activity. At all concentrations of acetaldehyde and all concentrations of plasma-containing Factor XIII which were employed, prolongation of both clotting time and stabilization time was observed. The 11.2 mM acetaldehyde is within the range of daily acetaldehyde production to be predicted in severe alcoholics as a consequence of imbibing alcohol. The stabilization times measured for Factor XIIIa activity appear to be the most sensitive to acetaldehyde compared to acetaldehyde effects on thrombin, Factor Xa, and fibrinogen studied earlier in this laboratory, as well as Factors II, VII, and X.


Factor XIII Coagulation Acetaldehyde Alcoholism Transglutaminase 



The authors express their deep appreciation to Wilfredo Pacio, M.D., and Mrs. Glenna Pool of the clinical laboratory of Wood County Hospital for generously providing the normal pooled human plasma samples utilized in this study. They further acknowledge the assistance of Dr. Nancy Boudreau of BGSU for assistance with the statistical evaluation of the data.


  1. 1.
    Podolsky DK, Isselbacher KJ (1994) Alcohol-related liver disease and cirrhosis. In: Harrison’s principles of internal medicine, 13th ed. Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL (eds). McGraw-Hill, New York, pp 1483–1495Google Scholar
  2. 2.
    Crabb DW, Lumeng L (1989) Alcoholic liver diseases. In: Textbook of internal medicine. Kelly WN (ed). Lippincott, Philadelphia, pp 592–602Google Scholar
  3. 3.
    Skrzydlewska E, Worowski K (1984–1985) Influence of ethanol and acetaldehyde on blood coagulation. Rocs Akad Med Bialymst 29–30:153–162Google Scholar
  4. 4.
    Brecher AS (2005) The effect of acetaldehyde on plasma. In: Comprehensive handbook of alcohol related pathology. Preedy VR, Watson R (eds). Academic Press, Elsevier Science, London, pp 1223–1244Google Scholar
  5. 5.
    Lenehan JG, Smith K (1985) Hemostasis, 17th ed. General Diagnostics, Morris Plains, NJ, p 45Google Scholar
  6. 6.
    Lelbach WK (1976) Epidemology of alcoholic liver disease. In: Progress in liver diseases. Popper H, Schaffner F (eds). Grune & Stratton, New York, pp 494–515Google Scholar
  7. 7.
    Brecher AS, Hellman K, Basista MH (1997) A perspective on acetaldehyde concentrations and toxicity in man and animals. Alcohol 14:493–496PubMedCrossRefGoogle Scholar
  8. 8.
    Brecher AS, Adamu MT (2002) Short- and long-term effects of acetaldehyde on plasma. Alcohol 26:49–53PubMedCrossRefGoogle Scholar
  9. 9.
    Brecher AS, Koterba AP, Basista MH (1996) Coagulation protein function. III. Effect of acetaldehyde upon the activation of prothrombin. Alcohol 13:423–429PubMedCrossRefGoogle Scholar
  10. 10.
    Brecher AS, Koterba AP, Basista MH (1996) Coagulation protein function. IV. Effect of acetaldehyde upon factor X and factor Xa, the proteins at the gateway to the common coagulation pathway. Alcohol 13:539–545PubMedCrossRefGoogle Scholar
  11. 11.
    Sabol DA, Basista MH, Brecher AS, Haider K, Kleshinski J (1999) Coagulation protein function VII: diametric effects of acetaldehyde on factor VII and factor IX function. Dig Dis Sci 44:2564–2567PubMedCrossRefGoogle Scholar
  12. 12.
    Basista MH, Joseph A, Smolen, S, Koterba A, Brecher AS (1994) Acetaldehyde alters coagulation protein function. Dig Dis Sci 39:2421–2425PubMedCrossRefGoogle Scholar
  13. 13.
    Hatake K, Taniguchi T, Ouchi H, Sakaki N, Hishida S, Ijiri I (1990) Possible involvement of kinins in cardiovascular changes after alcohol intake. Pharmacol Biochem Behav 35:437–442PubMedCrossRefGoogle Scholar
  14. 14.
    Salaspuro M (1991) Epidemiological aspects of alcohol and alcoholic liver disease, ethanol metabolism and pathogenesis of alcoholic liver injury. In: Oxford textbook of clinical hepatology. McIntyre N, Benhamov JP, Bircher J, Rizzetto M, Rodes J (eds). Oxford Press, Oxford, pp 791–810Google Scholar
  15. 15.
    Watanabe A, Kobayashi M, Hobara N, Nakatsukasa H, Nagashima H, Fujimoto A (1985) A report of unusually high blood ethanol and acetaldehyde levels in two surviving patients. Alcohol Clin Exp Res 9:14–16PubMedGoogle Scholar
  16. 16.
    Bordalo O, Batista A, Geraldes J, Neto F, Mascarenhas F, Leitao N, Noronha M, Silva PE (1974) Clinical correlations in alcoholic patients without manifest cirrhosis. Am J Gastroenterol 61:371–378PubMedGoogle Scholar
  17. 17.
    Braun KP, Pavlovich JG, Jones DR, Peterson CM (1997) Stable acetaldehyde adducts: structural characterization of acetaldehyde adducts of human hemoglobin N-terminal B-globin chain peptides. Alcohol Clin Exp Res 21:40–43PubMedGoogle Scholar
  18. 18.
    Lin RC, Lumeng L, Shahidi S, Kelly T, Pound DC (1990) Protein-acetaldehyde adducts in serum of alcoholic patients. Alcohol Clin Exp Res 14:438–443PubMedCrossRefGoogle Scholar
  19. 19.
    Lin RC, Shahidi S, Kelly TJ, Lumeng C, Lumeng L (1993) Measurement of hemoglobin-acetaldehdye adduct in alcoholic patients. Alcohol Clin Exp Res 17:669–674PubMedCrossRefGoogle Scholar
  20. 20.
    Nagata N, Nishizaki Y, Watanabe N, Tsuda M, Matsuzaki S (1998) An enzyme immune assay for serum anti-acetaldehyde adduct antibody using low-density lipoprotein adduct and its significance in alcoholic liver injury. Alcohol Clin Exp Res 22(Suppl 3):150S–155SPubMedCrossRefGoogle Scholar
  21. 21.
    Nicholls RM, Fowles LF, Worrall S, de Jersey J, Wilce PA (1994) Distribution and turnover of acetaldehyde-modified proteins in liver and blood of ethanol-fed rats. Alcohol Alcohol 29:149–157PubMedGoogle Scholar
  22. 22.
    Niemela O (1999) Aldehyde-protein adducts in the liver as a result of ethanol-induced oxidative stress. Front Biosci 4:D506–D513PubMedCrossRefGoogle Scholar
  23. 23.
    Niemela O, Israel Y, Mizoi Y, Fukunaga T, Eriksson CJ (1990) Hemoglobin-acetaldehyde adducts in human volunteers following acute ethanol ingestion. Alcohol Clin Exp Res 14:838–841PubMedCrossRefGoogle Scholar
  24. 24.
    Niemela O, Parkkila S, Pasanen M, Iimur Y, Bradford B, Thuman RG (1998) Early alcoholic liver injury: formation of protein adducts with acetaldehyde and lipid peroxidation products, and expression of CYP2E1 and CYP3A. Alcohol Clin Exp Res 22:2118–2124PubMedCrossRefGoogle Scholar
  25. 25.
    Sorrell MF, Tuma DJ (1987) The functional implications of acetaldehyde binding to cell constituents. Ann NY Acad Sci 492:50–62PubMedCrossRefGoogle Scholar
  26. 26.
    Svegliati-Baroni G, Baraona E, Rosman AS, Lieber CS (1994) Collagen-acetaldehyde adducts in alcoholic and nonalcoholic liver diseases. Hepatology 20:111–118PubMedCrossRefGoogle Scholar
  27. 27.
    Wickramasinghe SN, Thomas S, Hasan R (1994) Reaction of 14C-acetaldehyde with whole blood in vitro: further evidence for the formation of unstable complexes with plasma proteins and red cells. Alochol Alcohol 29:51–57Google Scholar
  28. 28.
    Worall S, deJersey J, Wilce PA, Seppa K, Hurme L, Sillinaukee P (1996) Relationship between alcohol intake and immunoglobulin A immunoreactivity with acetaldehyde-modified bovine serum albumin. Alcohol Clin Exp Res 20:836–840CrossRefGoogle Scholar
  29. 29.
    Brecher AS, Hellman K, Dulin C Basista MH (1998) Coagulation protein function V: diminution of antithrombin III function by acetaldehyde. Dig Dis Sci 43:1746–1751PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Department of ChemistryBowling Green State UniversityBowling GreenUSA

Personalised recommendations